We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+11.27%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$15.6M
Cap. Flow
+$220M
Cap. Flow %
163.5%
Top 10 Hldgs %
31.52%
Holding
253
New
80
Increased
47
Reduced
36
Closed
74

Top Buys

1
HUM icon
Humana
HUM
+$4.21M
2
AMGN icon
Amgen
AMGN
+$3.4M
3
EHC icon
Encompass Health
EHC
+$3.34M
4
SLNO
Soleno Therapeutics
SLNO
+$3.29M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.9M

Top Sells

1
CNC icon
Centene
CNC
+$10.3M
2
UNH icon
UnitedHealth
UNH
+$4.9M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.17M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$3M
5
CON
Concentra Group Holdings
CON
+$2.39M

Sector Composition

1 Healthcare 51.79%
2 Financials 16.59%
3 Materials 5%
4 Technology 2.34%
5 Energy 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGX icon
26
Quest Diagnostics
DGX
$23.3B
$1.44M 1.07%
8,007
+1,168
+17% +$203K
AX icon
27
Axos Financial
AX
$5.66B
$1.43M 1.06%
+18,781
New +$1.27M
SEM
28
DELISTED
Select Medical
SEM
$1.42M 1.05%
+93,563
New +$1.46M
C icon
29
Citigroup
C
$217B
$1.4M 1.04%
16,433
-4,498
-21% -$325K
PGY icon
30
Pagaya Technologies
PGY
$1.43B
$1.34M 1%
+63,059
New +$897K
HBM icon
31
Hudbay
HBM
$9.04B
$1.31M 0.97%
123,152
+5,139
+4% +$42.8K
LH icon
32
Labcorp
LH
$23.2B
$1.24M 0.92%
+4,734
New +$1.15M
FUTU icon
33
Futu Holdings
FUTU
$13.3B
$1.24M 0.92%
+10,000
New +$1.02M
MRNA icon
34
PUT
Moderna
MRNA
$24.5B
$1.21M 0.89%
45,482
+45,252
+19,675% +$1.19M
VKTX icon
35
Viking Therapeutics
VKTX
$4.31B
$1.21M 0.89%
45,482
+21,512
+90% +$566K
CI icon
36
Cigna
CI
$74.5B
$1.2M 0.89%
+3,618
New +$1.17M
AA icon
37
Alcoa
AA
$11.6B
$1.16M 0.86%
39,245
+24,813
+172% +$670K
MREO
38
PUT
Mereo BioPharma
MREO
$49.5M
$1.03M 0.76%
2,303
+2,212
+2,431% +$5.34K
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$123B
$1.03M 0.76%
+2,303
New +$1.06M
EGO icon
40
Eldorado Gold
EGO
$7.28B
$992K 0.74%
48,754
-15,445
-24% -$301K
UMBF icon
41
UMB Financial
UMBF
$11.1B
$988K 0.73%
9,391
-2,568
-21% -$256K
PTGX icon
42
Protagonist Therapeutics
PTGX
$9.06B
$968K 0.72%
+17,520
New +$841K
CRH icon
43
CRH
CRH
$68.8B
$966K 0.72%
10,519
+917
+10% +$83.6K
AMGN icon
44
PUT
Amgen
AMGN
$198B
$915K 0.68%
659,413
+659,293
+549,411% +$187M
BAC icon
45
Bank of America
BAC
$430B
$889K 0.66%
+18,778
New +$790K
ACHC icon
46
Acadia Healthcare
ACHC
$3.17B
$876K 0.65%
38,626
-33,854
-47% -$802K
SSB icon
47
SouthState Bank Corp
SSB
$10.1B
$864K 0.64%
9,390
-7,955
-46% -$699K
EQX icon
48
Equinox Gold
EQX
$6.8B
$854K 0.63%
148,541
+72,509
+95% +$471K
RKT icon
49
Rocket Companies
RKT
$41.1B
$832K 0.62%
+58,677
New +$761K
COIN icon
50
Coinbase
COIN
$41.4B
$827K 0.61%
+2,359
New +$551K
1
2
3 4 5

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Persistent Asset Partners held 253 positions worth $135M, up 13% from $119M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Persistent Asset Partners deployed $220M of net new capital in Q2 2025, opening 80 new positions and adding to 47 existing holdings. Its largest new stake was Amgen: 12,000 shares worth $3.35M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 61% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $3.17M trimmed.

  • Persistent Asset Partners's largest Q2 2025 buy was Amgen: 12,000 shares worth $3.35M.
  • Persistent Asset Partners added most to Humana in Q2 2025, an estimated $4.21M increase.
  • Persistent Asset Partners's biggest Q2 2025 reduction was Regeneron Pharmaceuticals, cutting an estimated $3.17M.
  • Persistent Asset Partners fully exited Centene in Q2 2025, selling an estimated $10.3M.
  • Persistent Asset Partners's ten largest holdings make up 32% of its $135M portfolio in Q2 2025.
  • Persistent Asset Partners opened 80 new positions and closed 74 in Q2 2025.
  • Persistent Asset Partners's portfolio value rose 13% quarter-over-quarter to $135M.

Based on Persistent Asset Partners's 13F filing for Q2 2025, filed 11 Aug 2025.